Calliditas Q1 2022: Early US sales support with a positive outlook - Redeye

Calliditas recorded Q1 sales are SEK 50m in Q1 compared with SEK 0m in 2021, and Tarpeyo product sales accounted for SEK 18m. This is in effect related to February to March 2022. More importantly, Calliditas can point to a “strong interest” in Tarpeyo as recorded by the 40 specialist sales force.

Länk till analysen i sin helhet: https://www.redeye.se/research/842442/calliditas-q1-2022-early-us-sales-support-with-a-positive-outlook?utm_source=finwire&utm_medium=RSS